PsyBio Therapeutics Announces Retention of Market Maker
March 04, 2021 08:08 ET | Source: PsyBio Therapeutics Corp. PsyBio Therapeutics Corp.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) PsyBio Therapeutics Corp. (TSXV:PSYB) (“
PsyBio” or the “
Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt of approval by the TSX Venture Exchange (“
TSXV”), it has retained Generation IACP Inc. (“
Generation”) to provide market making services with the objective of maintaining a reasonable market and improving the liquidity of PsyBio shares traded on the TSXV. PsyBio and Generation are unrelated and unaffiliated entities. Generation is a member of the Investment Industry Regulation Organization of Canada (IIROC) and a member firm of the TSXV.